H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents
Yoon, Joo Heung
MetadataShow full item record
CitationLee, Dongwon, Soochan Bae, Donghyun Hong, Hyungsuk Lim, Joo Heung Yoon, On Hwang, Seunggyu Park, Qingen Ke, Gilson Khang, and Peter M. Kang. 2013. “H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents.” Scientific Reports 3 (1): 2233. doi:10.1038/srep02233. http://dx.doi.org/10.1038/srep02233.
AbstractThe main culprit in the pathogenesis of ischemia/reperfusion (I/R) injury is the overproduction of reactive oxygen species (ROS). Hydrogen peroxide (H2O2), the most abundant form of ROS produced during I/R, causes inflammation, apoptosis and subsequent tissue damages. Here, we report H2O2-responsive antioxidant nanoparticles formulated from copolyoxalate containing vanillyl alcohol (VA) (PVAX) as a novel I/R-targeted nanotherapeutic agent. PVAX was designed to incorporate VA and H2O2-responsive peroxalate ester linkages covalently in its backbone. PVAX nanoparticles therefore degrade and release VA, which is able to reduce the generation of ROS, and exert anti-inflammatory and anti-apoptotic activity. In hind-limb I/R and liver I/R models in mice, PVAX nanoparticles specifically reacted with overproduced H2O2 and exerted highly potent anti-inflammatory and anti-apoptotic activities that reduced cellular damages. Therefore, PVAX nanoparticles have tremendous potential as nanotherapeutic agents for I/R injury and H2O2-associated diseases.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11717603
- HMS Scholarly Articles